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This paper explores the contested issue of the dispensing fee for medications in 
South Africa. Focusing on the dispute between organised pharmacy and the 
Health Department, it follows the history of the negotiations, traces possible 
implications, outlines key perceived problems with the policy, and explores 
possibilities for its resolution. The paper draws on published data and 
documents from government and pharmacy representatives and supplements this 






















Pricing Committee (PC): Appointed by the Health Minister to make recommendations 
leading to regulations on a transparent pricing system for all medicines – including 
the formulation of a single exit price and a dispensing fee - for anyone licensed to 
dispense  
Pharmaceutical Society of South Africa (PSSA): Organisation of individual pharmacists 
dealing with industry-wide legal representation, professional development, and 
public affairs 
United South African Pharmacies (USAP): Organisation of smaller infrastructure, 
helping independent community-practice pharmacies mainly in negotiations with 
medical schemes, defers legal issues to the PSSA. 
Pharmacy Stakeholders Forum (PSF): Formed jointly by the PSSA and USAP to 
negotiate a dispensing fee with the Health Department  
South African Pharmacy Council: Formed under the 1974 Pharmacy Act to advise 
Health Minister on matters relating to pharmacy; registers pharmacies for practise 





The pricing of medicines in South Africa has historically been unregulated and 
non-transparent. Pharmacies are free to levy a range of fees in dispensing to the 
general public despite an ongoing effort by the government to standardise fees in 
order to contain health care costs and protect consumers. Dispensing fee 
legislation, proposed in 1997 and finally applied in 2003, was meant to level the 
cost of any given medication at any given pharmacy by uniform standards of 
transparency. The architects of the 1997 Medicines Amendment Act sought to 
eliminate extraneous mark-ups (administration fees, shelving fees, etc) used at 
individual pharmacies by requiring each medicine to be sold by the pharmacy at 
its single exit price (SEP) with the addition of a uniform dispensing fee for 
profit. 
 
Debate rose immediately and continues over how this fee should be set.  
Concerned parties include representatives of civil society looking out for 
affordability, medical schemes whose policies change in accordance with drug 
pricing, pharmacy owners and employees with their various consortia, the 
consumers themselves, and a mediating Health Department billed with 
balancing these interests. 
 
But six years of planning and another six of attempted practise have seen 
communication breakdown between government and stakeholders, inadequate 
and un-enforced policy announcements, and unresolved negotiations causing 
disruption in the market between consumer and pharmacist. No appropriate fee 
can be determined without weighing all interests involved, but the scope of this 
paper will centre on the history, outlook and impact of pricing negotiations 
between organised pharmacy and government representatives. 
  
 
History of the negotiations 
 
In 1997, the Health Department issued the Medicines Amendment Act to add 
pricing regulations to the 1965 Medicines and Related Substances Control Act.  
The new bill established a single exit price for all medications – a fixed selling 
price down the chain from manufacturer to distributor to consumer – and called 
for the establishment of a Pricing Committee (PC) to determine the dispensing 
fee that was to replace cost mark-ups in pharmacies.1 By 2003, the Pricing 
                                                 
1 Medicines Amendment Act, 1997. Section 22G 
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Committee had proposed its first draft: an allowable fee of 24% of the SEP with 
a cap of R24. 
 
The fee was adjusted to 26% / R26 after submissions by the Pharmaceutical 
Society of South Africa (PSSA), but even so, the announcement of the fee in 
April 2004 was met with immediate objection. Pharmacy representatives warned 
of inadequate returns and questioned the decision-making methods and 
transparency of the PC. The PSSA proposed a tiered system based on a SEP 
with an average fee of R37, but this was ignored.2 
 
Starting in the second half of 2004, the PSSA led a successful legal challenge to 
the new regulations. The 26% / R26 plan was suspended in a 20 December 
ruling by the Supreme Court of Appeal and discarded by the Constitutional 
Court on 30 September 2005. The Constitutional Court ordered that the 
Medicines Amendment Act be kept but renegotiated by the Health Department 
and organised pharmacy within 60 days.3 In order to renegotiate the fee and 
collaborate more closely with the Health Department, the PSSA and USAP 
joined with several smaller community pharmacy groups to form the Pharmacy 
Stakeholders Forum (PSF), which came to represent about 80% of pharmacy 
business in South Africa.4 
 
The period between April (when the fee was announced) and December 2004 
(when the regulations were suspended) would be the closest the dispensing fee 
came to legal enforcement. According to Ivan Kotzé, legal director for the 
PSSA, the Health Department threatened to charge any pharmacy levying fees 
above 26% / R26 for these months, but the PSSA’s legal team promised to 
defend any pharmacy so charged and none, in the end, ever was.  
 
Negotiations following the Constitutional Court ruling continued to break down. 
Talks between the PSF and Health Department amounted to a series of policy 
announcements open for comment, with none ever agreed upon or implemented. 
The next push at legislation began in March 2006, when the PSF and PC settled 
on the same set of pharmacy financial data and – supposedly- a common means 
of analyzing it. Their findings for the cost of dispensing were discrepant, 
though: the PC arrived at R19.46 and the PSF at R30 for the cost incurred per 
                                                 
2 2007 PSSA Conference Document (p.1) 
3 “Court orders review of medicine-dispensing fees.” Mail and Guardian, 30 September 2005. 
<http://www.mg.co.za/article/2005-09-30-court-orders-review-of-medicinedispensing-fees>. 
4 2007 PSSA Conference Document (p. 2) 
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item dispensed at a community pharmacy (i.e. one without a wholesaler’s 
license).5  
 
Following these findings, a PC report to the Health Minister led to new fee 
announcement on 31 October 2006. Though based on a more comprehensive 
cost assessment, the average R21.46 per item proposed was considered to be 
well below the break-even point for community pharmacy and unmindful of 
those in rural and underserved areas.6 From the side of organised pharmacy, this 
lower-cap announcement was inconsistent with the Constitutional Court ruling, 
the process of its determining being neither collaborative nor transparent. The 
PC used a new financial model not approved by the PSF, according to Kotzé, 
and took its data on the cost of dispensing from a different year than data on the 
actual number of products dispensed. 
 
Just days after the R21.46 fee was announced in a December 2006 Gazette, the 
PSF met with the Director General and Deputy-Director of Health as well as the 
PC Secretariat in hopes of deferring it. The PSF submitted a report to the Health 
Minister emphasising the differences between its findings and those of the PC.  
When the Minister decided against deferment on 15 December, the PSF filed an 
application and was awarded urgent interim relief by the High Court, allowing 
pharmacies to charge an individualised dispensing fee in accordance with 
specific costs and income needs.7 
 
In the end, negotiations had failed and reverting to the courts would prove no 
more productive. The PSF filed a Rule 35 notice in the High Court on 21 
December 2006, ordering the Health Department to supply a full record of its 
decision making process (including pharmacy financial survey data, government 
documents and phone records) so that the process leading to its R21.46 
announcement could be seen plainly and scrutinised by the Court and the PSF. 
By June 2007, after continuous debate over pharmacy confidentiality and the 
documents that should or should not be included, the record filed by the Health 
Department was still considered incomplete by the PSF.8 At this point, the PSF 
shifted focus to out-of-court correspondence with PC and Health Department 
representatives in hopes of settling the issue directly. 
 
Since 2007, announcements by the Health Department have been shaped and 
discarded by these meetings with organised pharmacy. The latest came in a June 
                                                 
5 2007 PSSA Conference Document (p. 3) 
6 2007 PSSA Conference Document (p. 3) 
7 2008 PSSA Conference Document (p. 8) 
8 2008 PSSA Conference Document (p. 3-7) 
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2009 Gazette, proposing a tiered structure with a maximum 36% on SEP. The 
period for public commentary was extended to 31 July, but as of late August, the 
time of writing, it appears no further action has been taken.9 
 
In setting their various fees, individual choice affects business viability in a 
number of ways from pharmacy to pharmacy. Some stick to the 26% / R26 
policy while others have set higher fees, a distinction that often separates large 
wholesale chains that can afford the low fee, like Clicks,10 from smaller retail 
(i.e. “community”) pharmacy that cannot. Though no pharmacy has been forced 
to set a fee against its choosing, there is general agreement among pharmacists 
and their representatives that the industry is hurting and that government’s 
mismanagement of pricing regulations is largely to blame. The following are 
commonly perceived problems amongst South African pharmacy owners that 
have been attributed to dispensing fee legislation. The extent to which this is 
true, however, is still an open question. 
  
   
Problems facing organised pharmacy 
 
 
Failure of community pharmacy 
 
The survival of community pharmacy is the broadest and most cited concern 
over dispensing fee legislation. These are small chains or independent retailers 
with no wholesaler’s license and a narrower product base than supermarket 
dispensaries or large corporate chains like Clicks.   
 
Of the 2,467 pharmacies whose cost and pricing data was supposedly used to 
inform the 2006 fee proposals, an estimated 1,500 are community pharmacies 
that “serve where they’re needed,” says Gus Ferguson, Director of USAP. The 
PSSA notes that independent pharmacy takes a larger share in rural and 
disadvantaged communities, as corporate chains do not venture into these 
areas.11 
 
                                                 
9 Government Gazette (No. 32330) Notice on the Medicines and Related Substances Act, 
1965. 19 June 2009; and Amendment for extended commentary. 20 July 2009. 
10 Negotiations over drug pricing have helped cause an estimated 5-6% drop in gross profit 
since 2003, but Clicks continues to sell medication at its SEP plus a dispensing fee or 26% 
with an R26 cap for prescriptions over R100. No administration fees are charged. Interview 
with Kobie Visagie, Manager of Clicks on Glengarriff, Sea Point (April 2009). 
11 2007 PSSA Conference Document (p. 4) 
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The lack of a wholesaler’s license prevents community pharmacies from buying 
directly from the medicine’s manufacturer or primary importer to South Africa. 
Whereas Clicks has direct access and the power to negotiate bonuses with 
distributors, community pharmacies deal through intermediaries. With their 
broader product base, corporate chains are also better insulated against revenue 
loss from fees on medication sales. Kobie Visagie, manager at a Clicks store, 
notes little change in the type of products stocked and sold over the last five 
years while the manager of an independent pharmacy in Muizenberg- name 
withheld for the sake of anonymity- relates the loss of an unprofitable toiletries 
and infant department. Although the dispensing fee does not affect these items 
directly, he attributes the loss to a general difficulty attracting customers with 
his higher medication prices. Independents without an adaptive strategy are 
forced to narrow their product stock while levelling higher fees, which 
inevitably puts pressure on profit margins and has reportedly led to the closure 
of many small pharmacies.  
 
Of prime concern in the closure of community pharmacies is whether they need 
replacing. Visagie says that Clicks participates in mergers when independents 
close, but admits that new pharmacies are often not set up where the old were 
buried. Given constraints on the consumer in terms of time and travel costs, and 
the share independent pharmacies have in rural and underserved areas, their 
closure may result in problems for access. In response to the closures, says Gus 
Ferguson of USAP, the Health Department has licensed a number of public 
pharmacies, but these also tend not to take up the reins in places where 
community pharmacy is lost.  
 
Data on pharmacy openings and closures from the South African Pharmacy 
Council dates to 2005, but illustrates a trend that may continue currently. Table 
1 compares the presence community pharmacy to wholesaler pharmacy. Aside 
from its larger presence across the country, there are more community 
pharmacies per wholesale pharmacy in rural provinces like the Northern Cape 
and Mpumalanga than there are in more urban provinces like Gauteng and the 











Ratio, Community per 
Wholesale Pharmacy 
GT 890 218 4.082568807 
KZN 461 42 10.97619048 
WC 424 61 6.950819672 
EC 190 20 9.5 
MP 142 3 47.33333333 
NW 134 5 26.8 
FS 128 13 9.846153846 
LM 100 7 14.28571429 
NC 53 2 26.5 
Source: South African Pharmacy Council (2005) 
 
If community pharmacy has a greater presence in rural areas, and if ownership is 
generally changing from community to wholesale, which Hall states it is,12 there 
is little indication that wholesalers are opening in the same areas. Table 2 shows 
rural provinces like KwaZulu Natal and the Eastern Cape with no net gain in 
wholesalers to make up for the loss in community pharmacies, Limpopo being 
the notable exception. With its largest gains in Gauteng and the Western Cape, 
wholesale pharmacy continues to show preference for the more urban provinces. 
 
Table 2 adds dispensaries in government hospitals and clinics because these are 
likely to serve poor populations with fewer alternatives in seeking medication. 
Community pharmacy shows the biggest net loss and public institutional clinics 
the biggest net gain, but Elsje Hall points out the fact that a number of public 
pharmacies were opened on or near military bases.13 Names on the register are 
not all clear, but it appears that at least 8 and at most 14 of the openings have a 
military affiliation. Civilians would presumably have limited or no access to 
such pharmacies.   
 
The South African Pharmacy Council tracks other categories of pharmacy, but 
these are the most relevant the potential problem of access and ongoing debate 
between organised pharmacy and government. The data is somewhat is 
outdated; a more recent count would help support the popular idea within 
organised pharmacy that failed negotiations continue to weigh on community 
retailers. 
 
                                                 
12 Hall, p. 416: “at least 27 per cent of pharmacies that opened their doors from January 2004 
were owned by big business, for example Shoprite Checkers and New Clicks.” 
13 Hall, Elsje. Human Resources Development and Review 2008, Ch. 19: Pharmacists. HSRC 
Press 2008 (p. 416). 
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Table 2. Number of registered openings and closures in 2004 












GT 32 1 9 16 6 13 -7 
KZN 8 1 1 4 3 1 -2 
WC 8 1  12 11 2 16 
EC 3  1 1 4 1 2 
MP 1  1 1 1 1 1 
NW 5 4 1 5   -5 
FS 3  1   1 -3 
LM 3   8 2 1 8 
NC    1 1  2 
TOTAL 63 7 4 48 28 20 12 
Source: South African Pharmacy Council (2005) 
 
 
Inconsistent pricing under uncertainty 
 
In the thick of legal disputes and ongoing negotiations, the Medicines 
Amendment Act has clearly failed to do what it originally sought: to ensure that 
consumers pay the same price for the same medicine at any pharmacy.  
Corporate chains are able to follow the 26% / R26 cap from 2004 while others, 
mostly community retailers, make additional mark-ups to stay in business. 
Kobie Visagie, Clicks manager, relates that the chain has always adhered to the 
26% / R26 plan without charging extra administration fees. Vaughan Clark, 
owner of two independents in Hout Bay, uses a flat 38% mark-up.14 “Business,” 
he says, “wouldn’t be able to survive on anything less.”  
 
The independent manager in Muizenberg uses a tiered structure with rates 
higher than those proposed by government thus far. He cites the Medicines 
Amendment Act as the beginning of a “disruptive effect.” Though no pharmacy 
has ever been forced to change its pricing plan, announcements by the 
government about levelling prices and by the Health Minister that consumers 
should “shop around for their medications” 15 put pressure on small pharmacies 
to fall in line with the corporate chains. “Either you stick to the 26/26 cap and 
                                                 
14 The 38% mark-up on prescriptions holds profits at 8.5-9%, which Clark considers 
necessary to both Wheeler’s and Sentinel pharmacies of Hout Bay in business. Interview with 
Vaughan Clarke, owner of Wheeler’s and Sentinel Pharmacies, Hout Bay (May 2009). 
15 Announcement of the New Dispensing Fee for Medicine from the Health Minister. 31 




risk going out of business, or you charge your own fee and risk going out of 
business,” he says.  
 
Consumer choice and adaptation by the supplier are part of any competitive 
market, but six years of publicising regulations without implementing or 
resolving them have left government with one foot in and one foot out of the 
regulatory arena. A market that once self-regulated has long been warned of 
change, but left wondering how and whether it will happen. 
 
The effect of pricing uncertainty on consumer choice depends on the ability of 
consumers to “shop around” given possible constraints on travel or restriction to 
a given pharmacy (and thus a given fee) by a hard-to-find medication.  
 
Their medical schemes, meanwhile, are accused by the PSSA of setting 
unreasonably low reimbursement rates and justifying them under conditions of 
uncertainty in the market.  Certain schemes have allegedly refused to increase 
reimbursements since 2005, sticking to the R26 cap and pressuring pharmacies 
to either adjust their dispensing fees or pass the excess on to the consumer.16 In 
the latter case, small pharmacies risk losing customers to corporate chains that 





The PSSA is particularly concerned with the Health Department’s apparent lack 
of concern for human resources in evaluating the cost of running a pharmacy. 
Underestimating the cost of pharmacists and their assistants was its biggest 
oversight in determining the R19.46 per item cost in 2006, according to the 
PSSA.17 Salaries for dispensary staff have to do with wider trends in pharmacy 
training and staffing. 
 
The general impression among pharmacists and their representatives is that there 
is an efflux of South African trained pharmacists from South Africa and that 
fewer students are choosing to enter the profession. A pharmacist two years out 
of school and now employed at Lakeside Pharmacy in Muizenberg says that job 
openings in her field have grown since 2003 due to drops in pharmacy school 
enrolment and a noticeable loss of South African trained pharmacists to more 
lucrative positions abroad. Vaughan Clark lost four pharmacists to America and 
one to Europe over the last three years.   
                                                 
16 2007 PSSA Conference Document (p. 2) 




Recruitment statistics from countries like the UK, US and Australia are difficult 
to come by, but various sources suggest “an outflow of skills.”18 And with the 
additional stress put on community pharmacy, those staying in South Africa 
have reason to be wary of where they enter practise. 
 
Enrolment and graduation numbers from pharmacy schools may also indicate a 
waning of confidence in pharmacy as a profession. Graduation rates for the 
B.Pharm- the first and most common degree for entrance into pharmacy 
practise- at Nelson Mandela Metropolitan University (NNMU) in Port Elizabeth 
shows a clear decline from 21.4% of 2002 enrolees graduating to 14% in 2003, 
the year Health Department first took action on medication pricing. Enrolment 
also declined from 330 in 2004 to 22 7 in 2009.19 Similar data from Rhodes 
University shows no clear decline in the proportion of entrants graduating over 
the same period, but retention over four years hovers around 60%.20 This brief 
analysis doesn’t account for the seven other pharmacy schools in South Africa 
(though not all train pharmacists for practise) or for students taking more than 
four years of study. 
 
Organised pharmacy tends to attribute the loss of skill and interest in the field to 
the struggle over medication pricing. A possible explanation may be the strain 
placed on the community pharmacy sector by competition from the large 
corporate chains. As ownership changes hands from community to corporate, 
the large chains gain an increasing share in job offerings and come to dictate 
industry-wide terms in hiring. Clark loses pharmacists due to an inability to 
compete with starting salaries offered elsewhere. Pharmacy closure has also 
concentrated consumers in fewer dispensaries. An independent manager in 
central Cape Town has lost employees and seen profits fall despite heavier 
consumer traffic. “Morale is low,” she relates.21 And the problem is not 
contained to small pharmacies: on first visit to the Glengarriff Clicks, an irate 
customer left the long queue and interrupted our interview, complaining at 
                                                 
18 The Organisation for Economic Cooperation and Development found 23 400 South African 
trained health workers (including pharmacists) practicing in western countries in 2001, which 
was about 10 per cent of all registered health professionals in South Frica (OECD 2004). 
Statistics South Africa reports an increase in emigration by pharmacists from 1992 to 2003. 
For others, see Hall p. 413. 
19 NMMU Pharm School Data (attached) 
20 Rhodes U Summary of Pharmacy Stats (attached) 
21 This independent retailer is represented by USAP. She started with the pharmacy 30 years 
ago and says 2006 was the biggest hit to the business: staff were lost to other employers, more 
customers were buying, and profits were hurting.  “It truly is a battle,” she says, “Morale is 
low.” Interview Cape Town CBD (May 2009). 
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volume that “one chemist cannot possibly serve all these people.” (Ms. Visagie 




Problems in government regulation 
 
Because it was never effectively enforced, the dispensing fee per se cannot be 
blamed for problems seen in South African pharmacy. More persuasive is the 
idea that the long process of resolution drags on the system, and that government 
mismanagement holds some of the blame. Negotiations fuel an uncertain 
market, debate expends time and resources, and organised pharmacy struggles to 
show commitment to a solution while still keeping to its own fees to safeguard 
business. Communication breakdown and policy disagreement could be 
minimised if a few problems internal to the Health Department could be 
addressed. The solution, it seems, will have to have as much to do with clear 
decision-making and enforcement as with the dispensing fee figure itself.  
 
 
The PC and methodology 
 
“The Pricing Committee remains problem number one,” said USAP Director 
Gus Ferguson during a phone interview in April 2009. The committee suffers 
structural problems, according the PSSA, and chief among them is the fact that 
key members are employed by the medical aid industry.22 Medical insurers stand 
to benefit from a low-capped dispensing fee and, as previously discussed, seem 
to be profiting to the detriment of the consumer in these times of uncertainty.     
 
Organised pharmacy cites the PC’s lack of a chartered accountant as evidence 
that the committee is not equipped to account accurately for the cost of running 
a pharmacy. Returning to the 2006 cost per item analyses, the industry’s R30 
figure was validated by Price Waterhouse Cooper, whereas the PC’s R19.46 had 
no outside validation. Delays in policy implementation have been attributed to 
“incorrect accounting interpretations.”23   
 
Also at issue is the PC’s exclusion of pharmacy costs outside the dispensary.24  
Though the fees proposed apply only to the dispensary, their financial 
                                                 
22 2007 PSSA Conference Document (p.3) 
23 2007 PSSA Conference Document (p.3) 
24 see Announcement of the New Dispensing Fee for Medicine from the Health Minister. 31 
October 2006. <http://www.doh.gov.za/docs/sp/2006/sp1031.html> 
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implications reach to wider concerns like property, utilities, staffing and product 
stocking. Dispensing fee policy and resultant financial constraints have in some 
cases forced pharmacies- community retailers especially- to make changes in 
staffing and in stocking of non-medication products like vitamins and toiletries. 
 
Problems internal to the PC and inconsistencies with the PSF led to 
discrepancies in cost projections, and hence to the repeated objection to 
proposed legislation the part of organised pharmacy. After the Health 
Department’s announcement of an R21.46 fee, the PSF determined that of a 
sample of 2,467 community pharmacies, 1,557 would likely fail and another 368 
would be put at significant risk.25               
  
 
Non-transparency in government   
 
Vaughan Clark characterises the relationship between the organised pharmacy 
and the Health Department under Health Minister Manto Tshabalala-Msimang 
as one of “mistrust and disillusionment,” where meetings with representatives 
from the Department and the PC would lead immediately to incongruous policy 
announcements. Though established to collect information from all stakeholders 
and advise the Health Minister, the PC was thought to be misrepresenting 
organised pharmacy’s interests in communication with higher decision makers 
in the Health Department. 
 
The PSF hopes to see greater accountability and accessibility of these decision 
makers in government. Recent efforts to settle a fee out of court, and indeed 
much of the preceding legal history, involved meetings with representatives 
whose communication up the chain appeared warped to those on the ground.  
The 2006 PC report leading to the announcement of a R21.46 fee – “totally 
inaccurate” according to the PSSA – seemed to suggest to the Health Minister 
that the majority of stakeholders were in agreement when in fact this wasn’t the 
case.26 
 
The Health Department has also been tardy in its release of information 
concerning pharmacy closure. USAP projected closures of some 2-300 
pharmacies leading the Health Department’s 2004 release of the data, which, 
despite a flurry of new state licensures for railway dispensaries and state 
pharmacies, was around a “shockingly high” 500 according to Gus Ferguson.   
 
                                                 
25 2007 PSSA Conference Document (p. 4) 
26 2007 PSSA Conference Document (p. 3) 
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As mentioned previously, closure data from the South African Pharmacy 
Council reveals important gaps. Closures date to either 2004 or 2007 with no 
indication of turnover in between, and 2004 is the latest and only available 
report on the type and number of pharmacies operating in the country.27 The 
Council was established to register all pharmacists and pharmacies in the 
Republic. Composed of pharmacists itself, it seems in prime position to “advise 
the Minister or any other person on any matter relating to pharmacy,”28 as 
prescribed in the 1974 Pharmacy Act. In practise, though, pharmacists seem to 
regard the Council as less of an advisor and more of a tool of the Health 
Department. It “registers who the Health Department tells [it] to,” says Emily 
Kalonga, Officer of the Registration and Records department. Given some 
initiative of its own, and with its relationship to the Health Department 
recalibrated, the Pharmacy Council could be instrumental in channelling 
information on the state of pharmacy business to government and to the public.  
 
Issues of accessibility and transparency in decision-making are particularly 
disconcerting given the weight of responsibility vested in small groups to 
resolve these multilateral and complex negotiations. The 2008 Medicines 
Amendment Bill, for example, aimed to regulate costs in the private sector 
delivery of health services through the office of a Facilitator, one person 
appointed by the Health Minister to weigh the interests of many stakeholders 
(pharmacy, medical aid, civil society).29 The Treatment Action Campaign in a 
2008 release labels this office “entirely political” and “fundamentally mistaken,” 
calling for the increased independence of the Facilitator via parliamentary 
appointment.30 
Barbara Hogan’s appointment as Health Minister in 2008 was viewed as a 
positive step to some. She expressed interest in working toward an expedient 
and fair solution,31 and Clark and Ferguson both confirm that she met personally 
with representatives of the PSF. Though too soon to comment on the intentions 
of the new Health Department under Aaron Motsoaledi, they hope for the good 
                                                 
27 Website for the South African Pharmacy Council. Closures at 
<http://www.pharmcouncil.co.za/pharmacies_closed.asp>  National Count at 
<http://www.pharmcouncil.co.za/content.asp?ContentId=60> 
28 1974 Pharmacy Act, Section 3 
29 Government Gazette No. 611. 2 June 2008 (p. 3) 
30 Joint Submission on the Draft National Health Amendment Bill. The Treatment Action 
Campaign and the AIDS Law Project. 16 May 2008 (p. 4-5) 
<www.tac.org.za/community/files/SubmissionOnNationalHealthAmendmentBill20080516.pd
f> 
31 “Dispensing Fee- PSF and Minister of Health agree to further discussions: PSSA 
perspectives.” SA Pharmaceutical Journal. 2009. 76:1   <www.sabinet.co.za> 
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faith effort to carry over and take as a positive indicator the fact that the PSSA 
expects a more reasonable announcement as early as June 2009. 
 
   
Way Forward 
 
Given the lack of resolution and prolonged uncertainty in negotiations over the 
dispensing fee, the process itself must be examined and altered if any reasonable 
resolution is to be reached. No appropriate fee can be settled without the 
inclusion of all interests- civil society, pharmacy, government and medical 
schemes. The following suggestions focus on ways in which talks between 
pharmacy representatives and policy makers could proceed. 
 
As indicated by the High Court’s action in 2004, legal decisions will only result 
in the validation or disposal of a given dispensing fee and will not lead to 
settling the fee itself. The court will defer the proposal of an appropriate fee 
back to the PC and other stakeholders, and negotiations will begin again. Court 
action was deemed necessary to discard the 26% / R26 fee and to suspend the 
R21.46, but recent hearings over the Health Department’s decision making 
process seem to have consumed time and resources while getting nowhere. The 
PSSA took account of this in initiating its out of court meetings and the Health 
Department’s practise of making announcements for public comment without 
enforcing- though driving uncertainty in pricing- is at least beneficial in keeping 
the struggle out of court.  
 
Key policy makers in the Health Department must also engage more actively in 
the negotiation process. Barbara Hogan showed unprecedented initiative in this 
regard, but no one person can or should be charged with balancing all interests 
involved. Reaching a fair fee depends on the interpretation of common 
information by all vested parties, and breakdowns in negotiation were often the 
result of inconsistencies in the information itself. Publicising the information 
used to formulate decisions, or at least sharing it openly between the Health 
Department and organised pharmacy, would remedy situations like this. 
Confidentiality of financial data- the very source of argument over the Rule 35 
notice- should be respected, but updating and disseminating information on 
pharmacy closures would help to clarify and guide negotiations. Common 
knowledge of where and what pharmacies are closing (and how, when financial 
data is offered) would help all parties agree on the state of pharmacy in South 
Africa as well as a course of action. As mentioned before, the South African 





Where financial data is made available to both the Health Department and the 
PSF, the accounting process for costs of running a pharmacy should be reviewed 
and agreed on by both sides.  The PSSA calls for an independent accounting 
firm to determine the “true cost of dispensing”32 and though took a step in this 
direction by employing Price Waterhouse and Cooper in 2006 to assess its 
methods, cooperation between government and organised pharmacy in using 
such external assessors, has yet to materialise.  
 
 
Adaptation by community pharmacy 
 
Whether or not the dispensing fee is to blame, community pharmacy is under 
increasing pressure to compete with corporate chains. Among community 
pharmacists interviewed around Cape Town, the common tactic is to offer the 
customer an experience they wouldn’t find at a Clicks or Checkers. This means 
seeking products the consumer couldn’t find at a corporate retailer and 
personalizing the shopping experience. Either way, pharmacy managers hope to 
give consumers a reason to look beyond their higher fees. 
 
An independent manager in Muizenberg pushes his staff to advise customers on 
the ideal medicine for their concern or on which medicines and vitamins 
shouldn’t be mixed. He promotes his pharmacy in the area, canvassing at a local 
nursing home, and says that he seeks better products to stock his shelves- 
vitamins that need be taken less frequently, medicines confirmed by studies- 
than the corporate chains. 
 
In expanding its product base, an independent in city centre an unusual move in 
advertising. Rather than populating separate shelves, supplements and 
alternatives to prescription medication are displayed along the dispensary 
counter. Even without a standard dispensing fee, it’s possible that a high fee is 
more tolerable when it comes attached to a hard-to-find supplement rather than a 
prescription whose price could easily be compared elsewhere. A tub of “Immune 
Booster” caught my eye, with a label depicting a large red ribbon and, “Wandisa 
amashosa wehlise i-HIV,” which translates roughly to “together we fight HIV.” 
Though the packaging makes no overt claims at treating HIV infection, its hard-
to-miss display begs the possibility that profit incentives might drive pharmacies 
to market illegitimate treatments. 
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Vaughan Clarke, owner of two community pharmacies in Hout Bay, gives 
perhaps the most complete picture of adaptation in an uncertain market. He 
writes personalization into the staffing schedule, keeping dispensary shifts 
consistent so that routine customers see familiar faces, and in expanding services 
has gone so far as to open a basic clinic offering free consultation in the 
basement and to offer a medication delivery service that fills quickly and ships 
in temperature-controlled boxes. He keeps one pharmacy open for extended 
hours and seven days a week, and “works with the community to know that 
community pharmacy works.” 
 
He’s found means of survival, but admits to worsening conditions. A trained 
pharmacist, he now spends only 2-3 hours per day behind the dispensary counter 
and another 6-7 on overall business concerns. Due mainly to the high starting 
salaries commanded by pharmacists in a market that demands them, he’s lost 
four to the US and one to Europe over the last three years. To cope with the 
human resources problem, he’s reduced dispensary staffing to a system whereby 
one pharmacy school intern or internal trainee assists two licensed pharmacists 
behind the counter. This way, a student intern is trained in community 
pharmacy, a community member (non-pharmacy school graduate) is given the 
opportunity to further their career, and the cost of maintaining a dispensary is 
brought down. 
 
Clark accuses the public sector of “imposing a model into businesses that have 
run successfully for years.” He sees the need for cost control, but maintains that 
his higher mark-up is necessary and points to medical aids in adding that his is 
not the only business profiting in conditions of uncertainty. “A good business 
will survive no matter the conditions.” 
 
None of these solutions alleviate the whole problem. They simply enable 
community pharmacy to handle the yet unclear market effects of these 
negotiations. As these problems are defined with time, mediation between all 
concerned parties will hopefully lead to fair and lasting policy that resolves 
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